TI

Taro Pharmaceutical Industries

TARO

NYSEHealth Care

Income Statement

Total Revenue$659.76M

Gross Profit$349.56M

Operating Income$35.14M

EBITDA$137.8M

EBIT$104.91M

Pre-tax Income$82.67M

Net Income$60.31M

Balance Sheet

Net Cash$589.47M

Cash Equivalent$362.91M

Total Debt$0

Net Debt$-589.47M

Book Value$1.79B

Net Cash Per Share15.68

Book Value Per Share47.70